News & Events about Lantern Pharma Inc.
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('A.I.') and machine learning (M.L.) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that the...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('A.I.') and machine learning (M.L.) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has...
Globe Newswire
2 months ago
DALLAS, Dec. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire --Lantern Pharma Inc (Nasdaq: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") and machine learning (M.L.) platform to transform the cost, pace, and timeline of oncology drug ...
Business Wire
2 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('A.I.') and machine learning (M.L.) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence (A.I.) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will host its...